PlusPedia wird derzeit technisch modernisiert. Aktuell laufen Wartungsarbeiten. Für etwaige Unannehmlichkeiten bitten wir um Entschuldigung; es sind aber alle Artikel zugänglich und Sie können PlusPedia genauso nutzen wie immer.

Neue User bitte dringend diese Hinweise lesen:

Anmeldung - E-Mail-Adresse Neue Benutzer benötigen ab sofort eine gültige Email-Adresse. Wenn keine Email ankommt, meldet Euch bitte unter NewU25@PlusPedia.de.

Hinweis zur Passwortsicherheit:
Bitte nutzen Sie Ihr PlusPedia-Passwort nur bei PlusPedia.
Wenn Sie Ihr PlusPedia-Passwort andernorts nutzen, ändern Sie es bitte DORT bis unsere Modernisierung abgeschlossen ist.
Überall wo es sensibel, sollte man generell immer unterschiedliche Passworte verwenden! Das gilt hier und im gesamten Internet.
Aus Gründen der Sicherheit (PlusPedia hatte bis 24.07.2025 kein SSL | https://)

Bei PlusPedia sind Sie sicher: – Wir verarbeiten keine personenbezogenen Daten, erlauben umfassend anonyme Mitarbeit und erfüllen die Datenschutz-Grundverordnung (DSGVO) vollumfänglich. Es haftet der Vorsitzende des Trägervereins.

PlusPedia blüht wieder auf als freundliches deutsches Lexikon.
Wir haben auf die neue Version 1.43.3 aktualisiert.
Wir haben SSL aktiviert.
Hier geht es zu den aktuellen Aktuelle Ereignissen

RS Virus: Unterschied zwischen den Versionen

Aus PlusPedia
Zur Navigation springen Zur Suche springen
VisuellWikitext
Ossip Groth (Diskussion | Beiträge)
5.526 Bearbeitungen
Die Seite wurde neu angelegt: „miniatur|Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Siehe auch''' | align="left" width="800" | |- | bgcolor="#d…“
 
Ossip Groth (Diskussion | Beiträge)
5.526 Bearbeitungen
KKeine Bearbeitungszusammenfassung
 
Zeile 6: Zeile 6:
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| align="left" width="800" |
| align="left" width="800" |
<ref name="PMID17545486">A new mechanism for respiratory syncytial virus-induced beta2-adrenergic receptor insensitivity. Am J Physiol Lung Cell Mol Physiol 293(2):L279-80 (2007) PMID 17545486 </ref><ref name="PMID17872592">A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy. Am J Respir Cell Mol Biol 37(4):375-7 (2007) PMID 17872592 </ref><ref name="PMID11254547">Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 163(3 Pt 2):S18-21 (2001) PMID 11254547 </ref><ref name="PMID11254546">Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med 163(3 Pt 2):S14-7 (2001) PMID 11254546 </ref><ref name="PMID11254545">Potential mechanisms causing delayed effects of respiratory syncytial virus infection. Am J Respir Crit Care Med 163(3 Pt 2):S10-3 (2001) PMID 11254545 </ref><ref name="PMID18055698">Respiratory syncytial virus: a sleeping giant? Eur Respir J 30(6):1029-31 (2007) PMID 18055698 </ref><ref name="PMID11829086">Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. Eur Respir J 18(6):1044-58 (2001) PMID 11829086 </ref><ref name="PMID14654627">Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112(6 Pt 1):1442-6 (2003) PMID 14654627 </ref><ref name="PMID12949282">Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics 112(3 Pt 1):548-52 (2003) PMID 12949282 </ref><ref name="PMID223138">The pathogenesis of respiratory viral infection. Postgrad Med J 55(640):122-7 (1979) PMID 223138 </ref><ref name="PMID16113477">Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2(2):110-5 (2005) PMID 16113477 </ref><ref name="PMID12119057">Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. Respir Res 3 Suppl 1():S40-5 (2002) PMID 12119057 </ref><ref name="PMID12119055">Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res 3 Suppl 1():S26-33 (2002) PMID 12119055 </ref><ref name="PMID12119054">Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. Respir Res 3 Suppl 1():S21-5 (2002) PMID 12119054 </ref><ref name="PMID12119053">Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir Res 3 Suppl 1():S15-20 (2002) PMID 12119053 </ref><ref name="PMID12119052">Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res 3 Suppl 1():S8-14 (2002) PMID 12119052 </ref>
<ref name="PMID17545486">A new mechanism for respiratory syncytial virus-induced beta2-adrenergic receptor insensitivity. Am J Physiol Lung Cell Mol Physiol 293(2):L279-80 (2007) PMID 17545486 </ref><ref name="PMID17872592">A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy. Am J Respir Cell Mol Biol 37(4):375-7 (2007) PMID 17872592 </ref><ref name="PMID11254547">Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 163(3 Pt 2):S18-21 (2001) PMID 11254547 </ref><ref name="PMID11254546">Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med 163(3 Pt 2):S14-7 (2001) PMID 11254546 </ref><ref name="PMID11254545">Potential mechanisms causing delayed effects of respiratory syncytial virus infection. Am J Respir Crit Care Med 163(3 Pt 2):S10-3 (2001) PMID 11254545 </ref><ref name="PMID18055698">Respiratory syncytial virus: a sleeping giant? Eur Respir J 30(6):1029-31 (2007) PMID 18055698 </ref><ref name="PMID11829086">Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. Eur Respir J 18(6):1044-58 (2001) PMID 11829086 </ref><ref name="PMID14654627">Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112(6 Pt 1):1442-6 (2003) PMID 14654627 </ref><ref name="PMID12949282">Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics 112(3 Pt 1):548-52 (2003) PMID 12949282 </ref><ref name="PMID223138">The pathogenesis of respiratory viral infection. Postgrad Med J 55(640):122-7 (1979) PMID 223138 </ref><ref name="PMID16113477">Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2(2):110-5 (2005) PMID 16113477 </ref><ref name="PMID12119057">Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. Respir Res 3 Suppl 1():S40-5 (2002) PMID 12119057 </ref><ref name="PMID12119055">Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res 3 Suppl 1():S26-33 (2002) PMID 12119055 </ref><ref name="PMID12119054">Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. Respir Res 3 Suppl 1():S21-5 (2002) PMID 12119054 </ref><ref name="PMID12119053">Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir Res 3 Suppl 1():S15-20 (2002) PMID 12119053 </ref><ref name="PMID12119052">Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res 3 Suppl 1():S8-14 (2002) PMID 12119052 </ref><ref name="PMID17018467">Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease. Arch Pediatr Adolesc Med 160(10):1070-6 (2006) PMID 17018467 </ref><ref name="PMID14654627">Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112(6 Pt 1):1442-6 (2003) PMID 14654627 </ref>
 
 
|-
|-
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''

Aktuelle Version vom 14. April 2010, 14:17 Uhr

Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][8]


Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

Bibliographie

  1. ↑ A new mechanism for respiratory syncytial virus-induced beta2-adrenergic receptor insensitivity. Am J Physiol Lung Cell Mol Physiol 293(2):L279-80 (2007) PMID 17545486
  2. ↑ A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy. Am J Respir Cell Mol Biol 37(4):375-7 (2007) PMID 17872592
  3. ↑ Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 163(3 Pt 2):S18-21 (2001) PMID 11254547
  4. ↑ Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med 163(3 Pt 2):S14-7 (2001) PMID 11254546
  5. ↑ Potential mechanisms causing delayed effects of respiratory syncytial virus infection. Am J Respir Crit Care Med 163(3 Pt 2):S10-3 (2001) PMID 11254545
  6. ↑ Respiratory syncytial virus: a sleeping giant? Eur Respir J 30(6):1029-31 (2007) PMID 18055698
  7. ↑ Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. Eur Respir J 18(6):1044-58 (2001) PMID 11829086
  8. ↑ 8,0 8,1 Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112(6 Pt 1):1442-6 (2003) PMID 14654627
  9. ↑ Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics 112(3 Pt 1):548-52 (2003) PMID 12949282
  10. ↑ The pathogenesis of respiratory viral infection. Postgrad Med J 55(640):122-7 (1979) PMID 223138
  11. ↑ Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2(2):110-5 (2005) PMID 16113477
  12. ↑ Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. Respir Res 3 Suppl 1():S40-5 (2002) PMID 12119057
  13. ↑ Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res 3 Suppl 1():S26-33 (2002) PMID 12119055
  14. ↑ Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. Respir Res 3 Suppl 1():S21-5 (2002) PMID 12119054
  15. ↑ Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir Res 3 Suppl 1():S15-20 (2002) PMID 12119053
  16. ↑ Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res 3 Suppl 1():S8-14 (2002) PMID 12119052
  17. ↑ Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease. Arch Pediatr Adolesc Med 160(10):1070-6 (2006) PMID 17018467

Andere Lexika

Abgerufen von „https://h.suprapedia.de/w/index.php?title=RS_Virus&oldid=43249“